Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Les Choi
Institution:
Novartis (United States)
Observed institutions:
Novartis (Switzerland),
Novartis (United States)
OpenAlex ID:
A5110111588
Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma
2004
·
Miklos Pless
, Karim Belhadj
, et al.
·
Clinical Cancer Research
·
64
Clinical Pharmacology of Lumiracoxib: A Selective Cyclo-Oxygenase-2 Inhibitor
2005
·
Christiane M Rordorf
, Les Choi
, et al.
·
Clinical Pharmacokinetics
·
50
A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies.
2002
·
Lillian L Siu
, Eric K Rowinsky
, et al.
·
PubMed
·
50
Influence of food intake on the bioavailability and efficacy of oral calcitonin
2009
·
Morten A. Karsdal
, Inger Byrjalsen
, et al.
·
British Journal of Clinical Pharmacology
·
39
PDF
Pharmacokinetics of enteric‐coated mycophenolate sodium in stable pediatric renal transplant recipients
2005
·
Robert Ettenger
, Sharon Bartosh
, et al.
·
Pediatric Transplantation
·
30
Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced Cancers
2000
·
Honghui Zhou
, Les Choi
, et al.
·
The Journal of Clinical Pharmacology
·
30
PDF
Effect of Renal Function on the Pharmacokinetics of Valsartan
1997
·
Pratapa Prasad
, Surinder Mangat
, et al.
·
Clinical Drug Investigation
·
27
Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer
2004
·
Lia van Zuylen
, John Bridgewater
, et al.
·
Clinical Cancer Research
·
19
PDF
Show more works
View as search
Works count:
9
Citation count:
309
H-index:
8
I10-index:
8
Year
Topic
Type